Immune surveillance in colorectal carcinoma.

Immune surveillance in colorectal carcinoma.

Bibliografski detalji
Glavni autori:	Branch, P, Bicknell, D, Rowan, A, Bodmer, W, Karran, P
Format:	Journal article
Jezik:	English
Izdano:	1995

Slični predmeti

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.
od: Bicknell, D, i dr.
Izdano: (1996)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas.
od: Douglas, E, i dr.
Izdano: (2004)

Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas
od: Douglas, E, i dr.
Izdano: (2004)

Loss of human leukocyte antigen expression on colorectal tumor cell lines: implications for anti-tumor immunity and immunotherapy.
od: Browning, M, i dr.
Izdano: (1993)

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.
od: Bicknell, D, i dr.
Izdano: (1994)

Distribution of carcinoembryonic antigen and biologic behavior in colorectal carcinoma.
od: Kim, J, i dr.
Izdano: (1999)

Carcino-embryonic antigen may function as a chemo-attractant in colorectal-carcinoma cell lines.
od: Kim, J, i dr.
Izdano: (1999)

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma
od: Giannakis, Marios, i dr.
Izdano: (2018)

TUMOR ESCAPE FROM IMMUNE-RESPONSE BY VARIATION IN HLA EXPRESSION AND OTHER MECHANISMS
od: Bodmer, W, i dr.
Izdano: (1993)

Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines.
od: Browning, M, i dr.
Izdano: (1993)

Mechanisms of loss of HLA class I expression on colorectal tumor cells.
od: Browning, M, i dr.
Izdano: (1996)

Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.
od: Wong, N, i dr.
Izdano: (2004)

A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
od: Bicknell, D, i dr.
Izdano: (2005)

"Null" HLA A*0101 mutation identified in a colorectal cancer cell line
od: Bicknell, D, i dr.
Izdano: (2001)

DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
od: Tomlinson, I, i dr.
Izdano: (1997)

Local immune mechanisms in inflammatory bowel disease and colorectal carcinoma. Natural killer cells and their activity.
od: Gibson, P, i dr.
Izdano: (1986)

Mutational changes that lead to the loss of expression of HLA-A* in colorectal cancer
od: Bicknell, D, i dr.
Izdano: (2002)

Chromosome 11q in sporadic colorectal carcinoma: patterns of allele loss and their significance for tumorigenesis.
od: Tomlinson, I, i dr.
Izdano: (1996)

Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas.
od: Cottrell, S, i dr.
Izdano: (1992)

Surveillance for recurrence of colorectal cancer--reply.
od: Primrose, J, i dr.
Izdano: (2014)

Characterization of the E-cadherin/catenin complex in colorectal carcinoma cell lines.
od: El-Bahrawy, M, i dr.
Izdano: (2004)

Immune surveillance and AIDS progression.
od: Zinkernagel, R, i dr.
Izdano: (1997)

ABNORMALITIES IN HLA EXPRESSION ON COLORECTAL TUMOR-CELL LINES - IMPLICATIONS FOR ANTIGEN PRESENTATION
od: Browning, M, i dr.
Izdano: (1993)

APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits".
od: Rowan, A, i dr.
Izdano: (2000)

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
od: Woodford-Richens, K, i dr.
Izdano: (2001)

SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway
od: Woodford-Richens, K, i dr.
Izdano: (2001)

Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cells.
od: Emaduddin, M, i dr.
Izdano: (2008)

Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma.
od: Kim, J, i dr.
Izdano: (2000)

Bcl-2 expression in colorectal tumors: evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas.
od: Ilyas, M, i dr.
Izdano: (1996)

Correspondence - Immune surveillance and AIDS progression
od: Zinkernagel, R, i dr.
Izdano: (1997)

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas.
od: Hao, X, i dr.
Izdano: (2002)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers.
od: Woodford-Richens, K, i dr.
Izdano: (2001)

CDX2 mutations do not account for juvenile polyposis or Peutz-Jeghers syndrome and occur infrequently in sporadic colorectal cancers
od: Woodford-Richens, K, i dr.
Izdano: (2001)

Imaging immune surveillance by T cells and NK cells.
od: McCann, F, i dr.
Izdano: (2002)

Beta-catenin mutations in cell lines established from human colorectal cancers.
od: Ilyas, M, i dr.
Izdano: (1997)

Infection, immunity, and surveillance of COVID-19
od: Suthar, AB, i dr.
Izdano: (2022)

Immunity passports and contact tracing surveillance
od: Cofone, IC
Izdano: (2021)

Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.
od: Mann, B, i dr.
Izdano: (1999)

Direct and immune mediated antibody targeting of ERBB receptors in a colorectal cancer cell-line panel.
od: Ashraf, S, i dr.
Izdano: (2012)

Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis.
od: Fearnhead, N, i dr.
Izdano: (2002)